Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
RESEARCH TOOLSreports
Neuren Pharmaceuticals Limited (NURPF) Stock Price & Analysis
32 Followers
NURPF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.17 - $17.36
Previous Close$13.42
Volume57.00
Average Volume (3M)1.01K
Market Cap
$1.74B
Enterprise Value$1.72B
Total Cash (Recent Filing)AU$40.18M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)16.4
Beta1.80
Next Earnings
Aug 27, 2024EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.81
Shares Outstanding127,695,676
10 Day Avg. Volume146
30 Day Avg. Volume1,008
Standard Deviation0.28
R-Squared0.10
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$19.57Price Target Upside37.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Neuren Pharmaceuticals Limited News
PremiumCompany Announcements
Leadership Shift at Neuren Pharmaceuticals
PremiumCompany Announcements
Neuren Pharmaceuticals Expands Market Presence
PremiumCompany Announcements
Neuren Pharma Director Ups Shareholding
PremiumCompany Announcements
Neuren Pharmaceuticals Targets Neurodevelopmental Progress
PremiumCompany Announcements
Neuren Pharmaceuticals’ Lucrative Year with DAYBUE Success
PremiumCompany Announcements
Neuren Pharmaceuticals Reveals Promising Trial ResultsPremiumCompany Announcements
Neuren’s NNZ-2591 Shows Promise for Pitt Hopkins
PremiumCompany Announcements
Neuren Pharmaceuticals Awaits Key Trial ResultsOptions Prices
Currently, No data available
---
Ownership Overview
35.86% Insiders
2.50% Mutual Funds
2.89% Other Institutional Investors
58.75% Public Companies and
Individual Investors
NURPF FAQ
What was Neuren Pharmaceuticals Limited’s price range in the past 12 months?
Neuren Pharmaceuticals Limited lowest stock price was $6.17 and its highest was $17.36 in the past 12 months.
What is Neuren Pharmaceuticals Limited’s market cap?
Currently, no data Available
When is Neuren Pharmaceuticals Limited’s upcoming earnings report date?
Neuren Pharmaceuticals Limited’s upcoming earnings report date is Aug 27, 2024 which is in 54 days.
How were Neuren Pharmaceuticals Limited’s earnings last quarter?
Neuren Pharmaceuticals Limited released its earnings results on Feb 29, 2024. The company reported $0.572 earnings per share for the quarter, missing the consensus estimate of $0.653 by -$0.081.
Is Neuren Pharmaceuticals Limited overvalued?
According to Wall Street analysts Neuren Pharmaceuticals Limited’s price is currently Undervalued.
Does Neuren Pharmaceuticals Limited pay dividends?
Neuren Pharmaceuticals Limited does not currently pay dividends.
What is Neuren Pharmaceuticals Limited’s EPS estimate?
Neuren Pharmaceuticals Limited’s EPS estimate is $0.1.
How many shares outstanding does Neuren Pharmaceuticals Limited have?
Neuren Pharmaceuticals Limited has 130,065,670 shares outstanding.
What happened to Neuren Pharmaceuticals Limited’s price movement after its last earnings report?
Neuren Pharmaceuticals Limited reported an EPS of $0.572 in its last earnings report, missing expectations of $0.653. Following the earnings report the stock price went down -4%.
Which hedge fund is a major shareholder of Neuren Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in NURPF
---
Neuren Pharmaceuticals Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.57 (37.33% Upside)
$19.57 (37.33% Upside)
Blogger Sentiment
Bullish
NURPF Sentiment 96%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $65.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
64.36%
12-Months-Change
Fundamentals
Return on Equity
123.16%
Trailing 12-Months
Asset Growth
476.67%
Trailing 12-Months
Company Description
Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome.
---
NURPF Company Deck
---
NURPF Earnings Call
Q4 2024
0:00 / 0:00
---
NURPF Stock 12 Month Forecast
Average Price Target
$19.57
▲(37.33% Upside)
Technical Analysis
ACADIA Pharmaceuticals
―
Alnylam Pharma
―
Arrowhead Pharmaceuticals
―
Avadel Pharmaceuticals
―
Best Analysts Covering NURPF
1 Year
1 Year Success Rate
4/4 ratings generated profit
1 Year Average Return
+5.45%
reiterated a buy rating 14 days ago
Copying Elyse Shapiro's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +5.45% per trade.
---